Purchase Order HHSN268200700121P
Award Date 9/15/07
Potential Completion Date 9/30/08
Potential Value $100K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson). The contract, valued at $20,094,324.00, is for the provision of cancer information services. The contract is a definitive contract with a cost-no-fee pricing type and has an ultimate completion date of January 14, 2010. MD Anderson, a comprehensive cancer treatment and research center, has received...
- This is a three-year, $13,481,325.00 definitive contract awarded by the National Cancer Institute (NCI) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract supports a Phase II chemoprevention clinical trial in patients with adenomatous polyposis coli, a genetic condition that increases cancer risk. The contract does not have a small business set-aside designation. MD Anderson Cancer Center, a comprehensive cancer research and...
- This is a prime contract awarded by the U.S. government to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is for $6,155,674.00 and is a Definitive Contract with Cost No Fee pricing. The place of performance is Texas, USA. The contract is for biomedical (applied/exploratory) services and does not have a set-aside designation. MD Anderson Cancer Center, a comprehensive cancer treatment and research center, has received this prime...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract for $150,904.40 to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for an "Invasive Mold Data Acquisition" project. The contract does not have a set-aside designation and was awarded on July 15, 2019, with a completion date of July 14, 2020. MD Anderson Cancer Center is a comprehensive cancer treatment...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson) in the amount of $400,411.43. The contract was issued under the PREVENT Cancer Program (PREVENT) contract vehicle and supports the PRECLINICAL PREVENT CANCER PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS project with a period of performance through...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) to The University of Texas MD Anderson Cancer Center (MD Anderson) for $972,225.00 to provide medical physics peer review of radiation therapy quality assurance operations. The contract has a firm fixed price structure and a period of performance through March 12, 2025. MD Anderson is a child entity of the University of Texas System, which has a history of receiving federal contracts and grants across various...
- This federal contract award was made by the National Aeronautics and Space Administration (NASA) to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to conduct research on "Molecular Lesions in Dendritic Cells Cultivated in Modeled Microgravity." The $660,000.00 grant-funded research project ran from December 1, 2003 to September 30, 2008. The award was not set aside for any specific business category. MD Anderson is a comprehensive...
- This federal contract award, valued at $1,272,481.00, was issued by the National Cancer Institute to The University of Texas M.D. Anderson Cancer Center, a child entity of the University of Texas System. The contract is part of the "PREVENT Preclinical Drug Development Program (PREVENT)" and is focused on "TARGETING THE A2B ADENOSINE RECEPTOR FOR IMMUNOPREVENTION OF PANCREATIC CANCER." It is a firm fixed-price delivery order contract with a completion date of March 14,...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is part of the PREVENT Cancer Program, a preclinical research initiative focused on developing prevention strategies for breast cancer. The $714,123.60 contract supports "TARGETING THE MTOR PATHWAY FOR THE PREVENTION OF...
- This is a Delivery Order issued against the National Institutes of Health's PREVENT Cancer Program (PREVENT) Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The award, valued at $4,445.48, was made to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for a "CONTRACT ORIENTATION AND KICKOFF MEETING" related to the PRECLINICAL PREVENT CANCER PROGRAM initiative. The award has an ultimate completion date of December 31, 2015 and does...